BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC. Financials Beauty Farm Medical and Health Industry Inc.
Equities
2373
KYG0929L1041
Personal Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.18 HKD | -0.25% |
|
+3.85% | +46.03% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 2,375 | 3,543 | - | - |
| Enterprise Value (EV) 1 | 2,713 | 4,061 | 3,782 | 3,441 |
| P/E ratio | 10.7 x | 12.6 x | 10 x | 8.81 x |
| Yield | 4.27% | 3.46% | 4.39% | - |
| Capitalization / Revenue | 1.11 x | 1.34 x | 1.07 x | 0.96 x |
| EV / Revenue | 1.26 x | 1.54 x | 1.15 x | 0.93 x |
| EV / EBITDA | 4.4 x | 6.28 x | 5.16 x | 3.88 x |
| EV / FCF | 5,819,487 x | - | - | - |
| FCF Yield | 0% | - | - | - |
| Price to Book | 2.96 x | 3.45 x | 2.92 x | 1.95 x |
| Nbr of stocks (in thousands) | 235,796 | 235,796 | - | - |
| Reference price 2 | 10.07 | 15.02 | 15.02 | 15.02 |
| Announcement Date | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,635 | 2,145 | 2,637 | 3,297 | 3,695 |
| EBITDA 1 | - | 443.1 | 616.2 | 647.1 | 733.4 | 885.9 |
| EBIT 1 | - | 152.1 | 291.3 | 359.2 | 441.6 | 528.3 |
| Operating Margin | - | 9.3% | 13.58% | 13.62% | 13.39% | 14.3% |
| Earnings before Tax (EBT) 1 | - | 130.5 | 288.3 | 367.6 | 458.8 | 534.7 |
| Net income 1 | 193.5 | 103.1 | 215.7 | 272.4 | 349.8 | 396.2 |
| Net margin | - | 6.3% | 10.05% | 10.33% | 10.61% | 10.72% |
| EPS 2 | 1.940 | 0.5200 | 0.9400 | 1.196 | 1.500 | 1.705 |
| Free Cash Flow | - | - | 466.3 | - | - | - |
| FCF margin | - | - | 21.74% | - | - | - |
| FCF Conversion (EBITDA) | - | - | 75.67% | - | - | - |
| FCF Conversion (Net income) | - | - | 216.21% | - | - | - |
| Dividend per Share 2 | - | 0.3400 | 0.4300 | 0.5200 | 0.6600 | - |
| Announcement Date | 12/29/22 | 3/29/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 242 | 339 | 518 | 240 | - |
| Net Cash position 1 | - | - | - | - | - | 101 |
| Leverage (Debt/EBITDA) | - | 0.5456 x | 0.5499 x | 0.8008 x | 0.3267 x | - |
| Free Cash Flow | - | - | 466 | - | - | - |
| ROE (net income / shareholders' equity) | - | 46.2% | 43.5% | 28.9% | 38.2% | 23.1% |
| ROA (Net income/ Total Assets) | - | 3.16% | 7.44% | 8.7% | 9.05% | - |
| Assets 1 | - | 3,258 | 2,899 | 3,131 | 3,866 | - |
| Book Value Per Share 2 | - | 1.830 | 3.400 | 4.350 | 5.150 | 7.710 |
| Cash Flow per Share 2 | - | 1.910 | 2.720 | 4.280 | 4.970 | 5.400 |
| Capex 1 | - | 141 | 159 | 293 | 282 | 400 |
| Capex / Sales | - | 8.61% | 7.42% | 11.13% | 8.54% | 10.83% |
| Announcement Date | 12/29/22 | 3/29/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.02
CNY
Average target price
16.28
CNY
Spread / Average Target
+8.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +46.03% | 489M | |
| -25.39% | 493M | |
| -20.91% | 420M | |
| -19.18% | 222M | |
| -31.03% | 182M | |
| -6.33% | 117M | |
| +97.08% | 104M | |
| +0.97% | 84.08M | |
| -12.30% | 71.58M | |
| -1.92% | 60.62M |
- Stock Market
- Equities
- 2373 Stock
- Financials Beauty Farm Medical and Health Industry Inc.
